Innozide

Enalapril maleate and hydrochlorothiazide, the active ingredients in Innozide, are an ACE inhibitor and thiazide diuretic combination presented as an oral tablet for hypertension and heart failure treatment in adult patients. The formulation reduces blood pressure by inhibiting angiotensin‑converting enzyme and promoting sodium excretion, thereby improving cardiovascular outcomes. It is indicated for patients who require combined antihypertensive therapy and is often used when monotherapy does not achieve target blood pressure. The fixed‑dose combination simplifies dosing schedules and may improve adherence.

GNH USA supplies Innozide as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Innozide, a combined ACE‑inhibitor and thiazide diuretic, is employed in cardiovascular disease management.

- Hypertension: lowers elevated blood pressure when monotherapy is insufficient. - Heart failure: used as adjunct therapy to improve fluid balance and reduce cardiac workload.

Innozide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Cough: dry, persistent cough. - Dizziness: light‑headedness on standing. - Headache. - Increased urination.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue. - Severe hypotension: marked blood pressure drop. - Acute kidney injury: sudden decline in renal function. - Hyperkalemia: elevated potassium levels.

Before initiating Innozide, clinicians should consider several safety aspects. - Monitor blood pressure: ensure adequate control and avoid excessive lowering. - Assess renal function: check serum creatinine and eGFR before and during therapy. - Check electrolytes: especially potassium and sodium levels. - Avoid use in pregnancy: category D, risk to fetus. - Store at ambient temperature: keep below 25°C in original packaging, protect from moisture.

Innozide can interact with other medicines, requiring careful review.

Major Interactions (Avoid): - Potassium‑sparing diuretics or supplements: risk of hyperkalemia. - NSAIDs: may reduce antihypertensive effect and impair renal function. - Lithium: increased lithium levels and toxicity.

Moderate Interactions (Monitor Closely): - Other antihypertensives: additive blood pressure lowering. - ACE inhibitor or ARB combinations: increased risk of renal impairment. - Diuretics with other electrolytes: monitor for electrolyte imbalance.